Drugs Made In America Acquisition Corp. (DMAA)
Free
No email, no account, no signup.
Pulling latest news for Drugs Made In America Acquisition Corp.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Finance
Sector
Special Purpose Acquisition Company
Market Cap
$357M
We're already tracking Drugs Made In America Acquisition Corp. — here are the latest events we've registered
Recent News
- On April 29, 2026, the company signed a definitive merger agreement with Power Analytics Global Corp (PAGC), an AI and analytics provider, in a transaction valued at approximately $1 billion. This agreement follows a leadership transition in February 2026, during which Roger Bendelac was appointed as Chief Executive Officer.
Want to know how this news affects Drugs Made In America Acquisition Corp.? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Drugs Made In America Acquisition Corp. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.